Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese Patients
Clinical trial NCT02860624 · COMPLETED
Trial details
- NCT number
- NCT02860624
- Sponsor
- Livzon Pharmaceutical Group Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2013-04-01
- Enrollment
- 550
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.